Fabrinet CapEx increased by 23.5% to $63.76M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 123.6%, from $28.52M to $63.76M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 27.3% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.79M | $32.52M | $19.40M | $23.41M | $14.26M | $10.26M | $13.39M | $19.78M | $17.94M | $11.44M | $9.80M | $13.59M | $12.70M | $20.25M | $21.90M | $28.52M | $50.41M | $45.27M | $51.61M | $63.76M |
| QoQ Change | — | +154.3% | -40.4% | +20.7% | -39.1% | -28.1% | +30.5% | +47.8% | -9.3% | -36.3% | -14.3% | +38.6% | -6.5% | +59.4% | +8.1% | +30.2% | +76.8% | -10.2% | +14.0% | +23.5% |
| YoY Change | — | — | — | — | +11.5% | -68.5% | -31.0% | -15.5% | +25.8% | +11.5% | -26.8% | -31.3% | -29.2% | +77.1% | +123.4% | +109.9% | +296.8% | +123.5% | +135.7% | +123.6% |